These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6803278)
21. Plasma tryptophan and five other amino acids in depressed and normal subjects. DeMyer MK; Shea PA; Hendrie HC; Yoshimura NN Arch Gen Psychiatry; 1981 Jun; 38(6):642-6. PubMed ID: 7247626 [TBL] [Abstract][Full Text] [Related]
23. Plasma total and free tryptophan concentration in 'neurotic' and 'psychotic' depressive patients. Peet M; Moody JP; Worrall EP; Walker P; Naylor G Monogr Neural Sci; 1976; 3():33-6. PubMed ID: 979996 [TBL] [Abstract][Full Text] [Related]
24. Plasma tryptophan and trait aggression. Wingrove J; Bond AJ; Cleare AJ; Sherwood R J Psychopharmacol; 1999; 13(3):235-7. PubMed ID: 10512077 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of L-tryptophan in the reduction of sleep disturbance and depressive state in alcoholic patients. Asheychik R; Jackson T; Baker H; Ferraro R; Ashton T; Kilgore J J Stud Alcohol; 1989 Nov; 50(6):525-32. PubMed ID: 2685471 [TBL] [Abstract][Full Text] [Related]
26. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Benkelfat C; Ellenbogen MA; Dean P; Palmour RM; Young SN Arch Gen Psychiatry; 1994 Sep; 51(9):687-97. PubMed ID: 8080345 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge. Jagannathan V; Venitz J Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784 [TBL] [Abstract][Full Text] [Related]
28. A multivariate analysis of red blood cell membrane transports and plasma levels of L-tyrosine and L-tryptophan in depressed patients before treatment and after clinical improvement. Chiaroni P; Azorin JM; Bovier P; Widmer J; Jeanningros R; Barré A; Dufour H; Tatossian A; Tissot R Neuropsychobiology; 1990; 23(1):1-7. PubMed ID: 2280825 [TBL] [Abstract][Full Text] [Related]
29. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Maes M; Wauters A; Verkerk R; Demedts P; Neels H; Van Gastel A; Cosyns P; Scharpé S; Desnyder R Neuropsychopharmacology; 1996 Sep; 15(3):243-51. PubMed ID: 8873107 [TBL] [Abstract][Full Text] [Related]
30. Decreased tryptophan availability in endogenous depression caused by disturbed plasma leucine clearance. Møller SE; Kirk L Prog Neuropsychopharmacol; 1981; 5(3):277-9. PubMed ID: 7267845 [No Abstract] [Full Text] [Related]
31. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level. Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231 [TBL] [Abstract][Full Text] [Related]
32. A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection. Baranyi A; Meinitzer A; Stepan A; Putz-Bankuti C; Breitenecker RJ; Stauber R; Kapfhammer HP; Rothenhäusler HB Psychother Psychosom; 2013; 82(5):332-40. PubMed ID: 23942342 [TBL] [Abstract][Full Text] [Related]
33. Effects of oral contraceptives on tryptophan metabolism and vitamin B6 requirements in women. Brown RR; Rose DP; Leklem JE; Linkswiler HM Acta Vitaminol Enzymol; 1975; 29(1-6):151-7. PubMed ID: 1244084 [TBL] [Abstract][Full Text] [Related]
34. A placebo controlled evaluation of L-tryptophan in depression in the elderly. Cooper AJ; Datta SR Can J Psychiatry; 1980 Aug; 25(5):386-90. PubMed ID: 7407745 [TBL] [Abstract][Full Text] [Related]
35. Tryptophan metabolism in women using steroid hormones for ovulation control. Price JM; Thornton MJ; Mueller LM Am J Clin Nutr; 1967 May; 20(5):452-6. PubMed ID: 6023855 [TBL] [Abstract][Full Text] [Related]
36. Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Maes M; Verkerk R; Bonaccorso S; Ombelet W; Bosmans E; Scharpé S Life Sci; 2002 Sep; 71(16):1837-48. PubMed ID: 12175700 [TBL] [Abstract][Full Text] [Related]
37. The clinical significance of an elevated excretion of xanthurenic acid in psychiatric patients. Hoes MJ Acta Psychiatr Belg; 1979; 79(6):638-46. PubMed ID: 162316 [TBL] [Abstract][Full Text] [Related]
38. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers. Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856 [TBL] [Abstract][Full Text] [Related]
39. Deficient intestinal absorption of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies. Koskiniemi ML J Neurol Sci; 1980 Jul; 47(1):1-6. PubMed ID: 6157783 [TBL] [Abstract][Full Text] [Related]
40. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]